Abstract
RAPTA compounds, ([Ru(η6-arene)(PTA)Cl2], PTA = 1,3,5-triaza-7-phosphaadamantane), have been reported to overcome drug resistance in cisplatin resistant cells. However, the exact mechanism of these complexes is still largely unexplored. In this study, the interaction of some RAPTA compounds with the N-terminal fragment of the BRCA1 RING domain protein was investigated. The binding of the RAPTA compounds to the BRCA1 protein resulted in a release of Zn2+ ions in a dose and time dependent manner, as well as thermal alteration of ruthenated-BRCA1 proteins. Electron Transfer Dissociation (ETD) fragmentation mass spectrometry revealed the preferential binding sites of the RAPTA complexes on the BRCA1 zinc finger RING domain at a similar short peptide stretch, Cys24Lys25Phe26Cys27Met28Leu29 and Lys35 (residues 44-49 and 55 on full length BRCA1). Changes in the conformation and binding constants of ruthenium-BRCA1 adducts were established, resulting in inactivation of the RING heterodimer BRCA1/BARD1-mediated E3 ubiquitin ligase function. These findings could provide mechanistic insight into the mode of action of RAPTA complexes for on tested BRCA1 model protein.
References
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J TumminoD Hupe
Mar 30, 2001·The Journal of Biological Chemistry·R HashizumeT Ohta
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·H RuffnerI M Verma
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter S BrzovicRachel Klevit
May 17, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Viktor Brabec, Jana Kasparkova
Jun 10, 2005·Journal of Medicinal Chemistry·Claudine ScolaroPaul J Dyson
Mar 17, 2007·ChemMedChem·Angela CasiniLuigi Messori
Apr 28, 2009·Angewandte Chemie·Wee Han AngPaul J Dyson
May 22, 2010·Chemistry & Biodiversity·Adisorn RatanaphanPaul J Dyson
Aug 24, 2010·Chemistry & Biodiversity·Apichart AtipairinAdisorn Ratanaphan
Sep 30, 2010·Breast Cancer Research and Treatment·Apichart AtipairinAdisorn Ratanaphan
Oct 23, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Apichart AtipairinAdisorn Ratanaphan
Jan 22, 2011·Metallomics : Integrated Biometal Science·Susana M QuintalNicholas P Farrell
Nov 9, 2011·Analytical and Bioanalytical Chemistry·Samuel M MeierChristian G Hartinger
Dec 4, 2012·International Journal of Molecular Sciences·Korawan ChakreeAdisorn Ratanaphan
Mar 2, 2013·Chemical Society Reviews·Konstantin O ZhurovYury O Tsybin
Mar 14, 2013·Journal of Chemical Information and Modeling·Luc Patiny, Alain Borel
Oct 26, 2014·Investigational New Drugs·Suzanne LeijenJan H M Schellens
Mar 12, 2015·Scientific Reports·Andrea WeissPatrycja Nowak-Sliwinska
Oct 16, 2015·Cancer Biology & Therapy·Qiao LiBinghe Xu
Apr 5, 2016·Anti-cancer Agents in Medicinal Chemistry·Adisorn RatanaphanPaul J Dyson
Jun 22, 2016·Trials·Philip C SchoutenSabine C Linn
Jul 28, 2016·The Journal of Clinical Investigation·Yifan WangNeil Johnson
Apr 1, 2015·Chemical Science·Maria V BabakChristian G Hartinger